---
title: "Dynamic Clinical States in the First 72 Hours After Acute Stroke in ICU"
id: "medrxiv-5-dynamic-clinical-states-and-transitions-during-the-first-72-hours-of-intensive"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-5-dynamic-clinical-states-and-transitions-during-the-first-72-hours-of-intensive"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1?rss=1"
published_at: "2026-09-01T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Dynamic Clinical States in the First 72 Hours After Acute Stroke in ICU
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-5-dynamic-clinical-states-and-transitions-during-the-first-72-hours-of-intensive
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1?rss=1)
- **Published At:** 2026-09-01T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Retrospective cohort analysis of 6,368 adults with **acute stroke** from the MIMIC-IV v3.1 database examined physiological and neurological evolution during the first 72 hours of intensive care. - The 72-hour window was divided into twelve 6-hour epochs and modeled using a **hidden Markov model** on 21 neurological, physiological and organ-support variables. - Pre-specified criteria (statistical fit, restart stability, occupancy and clinical interpretability) guided selection of the number of states. - Four reproducible, clinically interpretable states were identified: **neurologically preserved–low support** (63.3% of windows), **neurological impairment–low support** (7.8%), **impairment–renal dysfunction** (11.8%), and **impairment–respiratory support** (17.1%). - Within 72 hours, 40.3% of patients transitioned between states at least once; transitions occurred bidirectionally rather than along a single severity gradient. - Although states were learned without outcome inputs, ICU mortality by last observed state ranged from 2.9% to 43.9%. - After adjustment for age, sex, stroke subtype and Charlson comorbidity index, the current state remained associated with subsequent organ-support escalation (new mechanical ventilation and vasopressor use within 12 hours) and with ICU death within 72 hours. - Reproducibility checks: state prevalence differed by at most 1.1 percentage points between training and test sets; 10 of 11 sensitivity analyses returned a stable four-state solution with adjusted Rand index between approximately 0.754 and 0.955. - Authors emphasize that the representation was reproducible in held-out data and across admission eras but requires external validation in an independent database before clinical application. - Data source and governance: analyses used the publicly available MIMIC-IV dataset (PhysioNet) under its data-use agreement; code will be made available on request.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=Uyx2SqZ7j1md54DVYnNRjtfb0dzphHVWq.Ydqwcrxqg-1788289509.1962278-1.2.1.1-BkPzw_BHW9KzUAiDcxA0__E7NQi62rNHa_vntG3fk4aFw0ueIuTM2EGDj9uLIhTK) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Dynamic Clinical States and Transitions During the First 72 Hours of Intensive Care After Acute Stroke [ View ORCID Profile](http://orcid.org/0000-0002-8904-3167)Ping LEI, [ View ORCID Profile](http://orcid.org/0000-0003-0270-2017)Yanyi XU, [ View ORCID Profile](http://orcid.org/0000-0003-4419-7004)Yuxia ZHANG doi: https://doi.org/10.64898/2026.08.30.26361738 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Ping LEI 1 Institute of Global Health, University of Geneva, Geneva, Switzerland; School of Public Health, Fudan University, Shanghai, China; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ping%2BLEI%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=LEI%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APing%2BLEI%2B) * [ORCID record for Ping LEI](http://orcid.org/0000-0002-8904-3167 "Open in new tab") * For correspondence: ping.pinglei@unige.ch Yanyi XU 2 Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yanyi%2BXU%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=XU%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYanyi%2BXU%2B) * [ORCID record for Yanyi XU](http://orcid.org/0000-0003-0270-2017 "Open in new tab") Yuxia ZHANG 3 Department of Nursing, Zhongshan Hospital, Fudan University, Shanghai, China * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuxia%2BZHANG%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=ZHANG%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuxia%2BZHANG%2B) * [ORCID record for Yuxia ZHANG](http://orcid.org/0000-0003-4419-7004 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1289761/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1289761/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1289761/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1289761/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1289761/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1289761/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: The condition of a patient with acute stroke often changes within hours of ICU admission. Prognostic work here targets fixed endpoints predicted from admission data, and trajectory phenotyping assigns one label per patient. We used longitudinal ICU data to identify interpretable dynamic clinical states, characterize transitions between them, and relate the current state to later events. Methods: Retrospective cohort study of 6368 adults with acute stroke in MIMIC IV v3.1. The first 72 h were divided into twelve 6-hour windows, and a hidden Markov model was fitted to 21 neurological, physiological and organ support variables. State number was chosen against criteria fixed before fitting: statistical fit, restart stability, state occupancy and clinical interpretability. Generalized estimating equations related the current state to new mechanical ventilation and vasopressor use within 12 h, and to ICU death within 72 h. Eleven sensitivity analyses assessed the robustness of the state solution. Results: Four states were selected: neurologically preserved-low support, neurological impairment low support, impairment renal dysfunction and impairment-respiratory support (63.3%, 7.8%, 11.8% and 17.1% of windows). Within 72 h, 40.3% of patients changed state at least once, and transitions ran in both directions rather than along a single severity gradient. States were identified without outcome data, yet ICU mortality by last state ranged from 2.9% to 43.9%. Adjusted for age, sex, subtype and Charlson index, the current state remained associated with organ-support escalation and death. State prevalence differed by at most 1.1 percentage points between training and test sets, and 10 of 11 sensitivity analyses gave a stable four-state solution (ARI 0.754 0.955). Conclusions: The early ICU course of acute stroke can be represented as movement among a small number of clinically interpretable states. The representation was reproducible in a held out set and across admission eras, but requires validation in an independent database before any clinical use. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Institutional Review Board of Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA, which reviewed the collection of the underlying patient data and creation of the MIMIC-IV research resource, granted a waiver of informed consent, and approved the data sharing initiative. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The dataset analyzed in this study is publicly available through PhysioNet (https://physionet.org/content/mimiciv/3.1/) to credentialed users who have completed the required training and signed the data use agreement. The data cannot be redistributed by the authors. Analysis code will be made available upon reasonable request. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.27.26361302v1 "Predicting COVID-19 hospitalisation and common disease risk from comorbid diagnoses in 13 million individuals")[Next ](https://www.medrxiv.org/content/10.64898/2026.04.11.26350590v2 "Policy Levers of HIV Control: Targeted Service Coverage, Financial Protection, and Estimated New HIV Infections in Southeast Asia, 2013-2022") Posted September 01, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/01/2026.08.30.26361738.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.30.26361738v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/01/2026.08.30.26361738.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Dynamic Clinical States and Transitions During the First 72 Hours of Intensive Care After Acute Stroke Ping LEI, Yanyi XU, Yuxia ZHANG medRxiv 2026.08.30.26361738; doi: https://doi.org/10.64898/2026.08.30.26361738 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361738v1%26text%3DDynamic%2520Clinical%2520States%2520and%2520Transitions%2520During%2520the%2520First%252072%2520Hours%2520of%2520Intensive%2520Care%2520After%2520Acute%2520Stroke "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361738v1%26t%3DDynamic%2520Clinical%2520States%2520and%2520Transitions%2520During%2520the%2520First%252072%2520Hours%2520of%2520Intensive%2520Care%2520After%2520Acute%2520Stroke "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361738v1%26title%3DDynamic%2520Clinical%2520States%2520and%2520Transitions%2520During%2520the%2520First%252072%2520Hours%2520of%2520Intensive%2520Care%2520After%2520Acute%2520Stroke%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361738v1%26title%3DDynamic%2520Clinical%2520States%2520and%2520Transitions%2520During%2520the%2520First%252072%2520Hours%2520of%2520Intensive%2520Care%2520After%2520Acute%2520Stroke "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.30.26361738) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.30.26361738v1&count=horizontal&via=&text=Dynamic%20Clinical%20States%20and%20Transitions%20During%20the%20First%2072%20Hours%20of%20Intensive%20Care%20After%20Acute%20Stroke&counturl=www.medrxiv.org/content/10.64898/2026.08.30.26361738v1 "Tweet This") ## Subject Area * [Intensive Care and Critical Care Medicine ](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (613) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (895) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (326) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4768) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (643) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1613) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15832) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6982) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1057) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4979) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1426) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1735) * [Hematology](https://www.medrxiv.org/collection/hematology) (581) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1334) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16242) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1161) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (663) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (720) * [Neurology](https://www.medrxiv.org/collection/neurology) (7190) * [Nursing](https://www.medrxiv.org/collection/nursing) (363) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1073) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1231) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1001) * [Oncology](https://www.medrxiv.org/collection/oncology) (3571) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1036) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (446) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (465) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1772) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (733) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (759) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5830) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9688) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2386) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1432) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1239) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (633) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (765) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (576) * [Surgery](https://www.medrxiv.org/collection/surgery) (766) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (302) * [Urology](https://www.medrxiv.org/collection/urology) (286) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community
## Related Clinical Research

- [2026 Stroke Rehabilitation Guideline: Start Early and Address Physical, Cognitive, and Mental Heal](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rehab-guidelines-emphasize-early-support-for-physical-cognitive-and.md)
- [Hormone replacement therapy timing and menopause type linked to dementia risk in large UK study](https://medichelpline.com/clinical-feed/medical-news-today-1-menopause-type-and-hrt-timing-influence-dementia-risk-large-study-suggests.md)
- [Increasing stroke risk in younger adults requires targeted prevention and updated risk assessment](https://medichelpline.com/clinical-feed/plos-medicine-0-stroke-risk-in-younger-age-groups-is-increasing-and-requires-targeted-prevention.md)
- [Trends in stroke incidence and modifiable risk factors in England (2018–2024): age-specific change](https://medichelpline.com/clinical-feed/plos-medicine-0-time-trends-in-stroke-incidence-and-modifiable-risk-factor-prevalence-in.md)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.